
Ginger Vieira
Our Experience: Taking GLP-1 Medications Like Ozempic & Trulicity with Type 1 Diabetes
Tidepool Loop FDA Clearance: Chatting with CEO Howard Look
This week’s FDA clearance of the new Tidepool Loop iPhone app means āloopingā could be even simpler and likely far…
Mark Cuban’s Cost Plus Drugs Tests New Insulin Program
You may have been the lucky recipient of an invitation to Mark Cuban’s Cost Plus Drug’s “Insulin Test Program” this…
7 Things People Say About Type 1 Diabetes That Drive Us CrazyĀ
Well, sure, we do want people to ask questions and try to learn more about type 1 diabetes. The problem…
5 Habits That Help Me Thrive with Type 1 Diabetes
Editorās note: This article is about Ginger Vieiraās personal experience managing type 1 diabetes. What works for her may not…
Our Research: Young People with T1D + Other Conditions Face Higher Risk of Severe Covid-19
Our research ā recently highlighted by the American Diabetes Association and Healio ā continues to demonstrate that children and young…
Our Published Quality Improvement Research of 2022: Changing T1D Healthcare
The T1D Exchange Quality Improvement Collaborative (T1DX-QI) published 18 manuscripts during 2022. This variety of robust and deeply impactful work…
DiabetesMine Innovation Summit Unveils New Tech & Products for Type 1 Diabetes
There is one common goal in the diabetes healthcare industry: we want to make life with type 1 diabetes (T1D)…
When Diabetes Clinics Collaborate: People with Type 1 Diabetes Reap the Benefits
With nearly 2 million people across the country living with type 1 diabetes (T1D) and thousands of endocrinology clinics, collaboration…
Delaying Type 1 Diabetes with Tzield: What’s the Process Really Like?
On November 17, 2022, the FDA approved a new drug that can delay the full onset of type 1 diabetes…